la prochaine session du DIU de Cytométrie en Recherche et en Clinique a obtenu, pour la seconde année, le label "AFC-Formation" délivré par l'Association Française de Cytométrie.

Les informations peuvent être consultées sur le site de l'EPHE :


Programme et stages Lyon 2012-2013

Programme et examens premier semestre

DESC 2012-2013

Questions d'examen 2011-2012
Programme de la première année du DESC 2011-2012, premier semestre
1e an - 1er sém 9-11 Fév 2012
Question d'examen 18 juin 2011Copie de Quest.Examen 18 juin
Résultats de l'examen du 18 juin 2011DESC Résultats examen 18 Juin 2011
Résultats de l'examen 2ème année DESC 2010-2011DESC 2e an 2010-11 Rés Examens

DIU Immunologie et Biothérapies 2012-2013

Le programme du DIU Immunologie et Biothérapies est disponibleProgramme DIU 2012 2013


The American Society for Blood and Marrow Transplantation is an international professional association that promotes the advancement of the blood and marrow transplantation field.  ASBMT members are both in clinical practice and in research, only recently have health professionals in the BMT field had an organization that focuses exclusively on their clinical and research interests.  Previously, they have had to rely on more general medical and scientific organizations.  The ASBMT Bylaws outline the purpose and structure for the Society.

des liens avec les instances de régulation, des informations sur les congrès , des webinars

Founded in 1996, FACT establishes standards for high quality medical and laboratory practice in cellular therapies. FACT is a non-profit corporation co-founded by the International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation (ASBMT) for the purposes of voluntary inspection and accreditation in the field of cellular therapy.

EMEA: European Medicines Agency - Science, medicines, health: The European Medicines Agency is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union.
regarder vaccins, monoclonaux, thérapie cellulaire

Founded in October 2009, Vaccine News Daily (VND) is an Internet-based newswire dedicated to 24/7 coverage of communicable diseases and vaccine development.
Today, with globalization facilitating the spread of disease and biological terror a constantly looming threat, the influx of need-to-know news has become overwhelming, and prevailing media outlets have proven ill-equipped to keep up.
Vaccine News Daily will fill this void, providing up-to-date information on vaccines and communicable diseases to help scientists, government officials, and the general public stay abreast of current concerns and new developments.
We're Chicago-based with staff writers and freelance correspondents stationed in and near all the major jurisdictions in the United States.